Report cover image

Global Venous Leg Ulcers Treatment Industry Growth and Trends Forecast to 2031

Publisher APO Research, Inc.
Published Oct 20, 2025
Length 103 Pages
SKU # APRC20548706

Description

Summary

According to APO Research, The global Venous Leg Ulcers Treatment market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for Venous Leg Ulcers Treatment is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Venous Leg Ulcers Treatment is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for Venous Leg Ulcers Treatment is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global manufacturers of Venous Leg Ulcers Treatment include Stratatech Corp, RMB-Research GmbH, RegeneRx Biopharmaceuticals Inc, Promore Pharma, NovaLead Pharma Pvt Ltd, MediWound Ltd, Leap Therapeutics Inc, Hypo-Stream Ltd and GangaGen Inc, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Venous Leg Ulcers Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Venous Leg Ulcers Treatment.
The Venous Leg Ulcers Treatment market size, estimations, and forecasts are provided in terms of sales volume (k units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Venous Leg Ulcers Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Venous Leg Ulcers Treatment Segment by Company

Stratatech Corp
RMB-Research GmbH
RegeneRx Biopharmaceuticals Inc
Promore Pharma
NovaLead Pharma Pvt Ltd
MediWound Ltd
Leap Therapeutics Inc
Hypo-Stream Ltd
GangaGen Inc
FirstString Research Inc
Factor Therapeutics Ltd
Daval International Ltd
CytoTools AG
CardioVascular BioTherapeutics Inc
Venous Leg Ulcers Treatment Segment by Type

HP-802247
Granexin
CVBT-141B
CureXcell
Others
Venous Leg Ulcers Treatment Segment by Application

Hospital
Clinic
Home Use
Venous Leg Ulcers Treatment Segment by Region

North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Venous Leg Ulcers Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Venous Leg Ulcers Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Venous Leg Ulcers Treatment.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Venous Leg Ulcers Treatment manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Venous Leg Ulcers Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

103 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Venous Leg Ulcers Treatment Market Size Estimates and Forecasts (2020-2031)
1.2.2 Global Venous Leg Ulcers Treatment Sales Estimates and Forecasts (2020-2031)
1.3 Venous Leg Ulcers Treatment Market by Type
1.3.1 HP-802247
1.3.2 Granexin
1.3.3 CVBT-141B
1.3.4 CureXcell
1.3.5 Others
1.4 Global Venous Leg Ulcers Treatment Market Size by Type
1.4.1 Global Venous Leg Ulcers Treatment Market Size Overview by Type (2020-2031)
1.4.2 Global Venous Leg Ulcers Treatment Historic Market Size Review by Type (2020-2025)
1.4.3 Global Venous Leg Ulcers Treatment Forecasted Market Size by Type (2026-2031)
1.5 Key Regions Market Size by Type
1.5.1 North America Venous Leg Ulcers Treatment Sales Breakdown by Type (2020-2025)
1.5.2 Europe Venous Leg Ulcers Treatment Sales Breakdown by Type (2020-2025)
1.5.3 Asia-Pacific Venous Leg Ulcers Treatment Sales Breakdown by Type (2020-2025)
1.5.4 South America Venous Leg Ulcers Treatment Sales Breakdown by Type (2020-2025)
1.5.5 Middle East and Africa Venous Leg Ulcers Treatment Sales Breakdown by Type (2020-2025)
2 Global Market Dynamics
2.1 Venous Leg Ulcers Treatment Industry Trends
2.2 Venous Leg Ulcers Treatment Industry Drivers
2.3 Venous Leg Ulcers Treatment Industry Opportunities and Challenges
2.4 Venous Leg Ulcers Treatment Industry Restraints
3 Market Competitive Landscape by Company
3.1 Global Top Players by Venous Leg Ulcers Treatment Revenue (2020-2025)
3.2 Global Top Players by Venous Leg Ulcers Treatment Sales (2020-2025)
3.3 Global Top Players by Venous Leg Ulcers Treatment Price (2020-2025)
3.4 Global Venous Leg Ulcers Treatment Industry Company Ranking, 2023 VS 2024 VS 2025
3.5 Global Venous Leg Ulcers Treatment Major Company Production Sites & Headquarters
3.6 Global Venous Leg Ulcers Treatment Company, Product Type & Application
3.7 Global Venous Leg Ulcers Treatment Company Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Venous Leg Ulcers Treatment Market CR5 and HHI
3.8.2 Global Top 5 and 10 Venous Leg Ulcers Treatment Players Market Share by Revenue in 2024
3.8.3 2023 Venous Leg Ulcers Treatment Tier 1, Tier 2, and Tier 3
4 Venous Leg Ulcers Treatment Regional Status and Outlook
4.1 Global Venous Leg Ulcers Treatment Market Size and CAGR by Region: 2020 VS 2024 VS 2031
4.2 Global Venous Leg Ulcers Treatment Historic Market Size by Region
4.2.1 Global Venous Leg Ulcers Treatment Sales in Volume by Region (2020-2025)
4.2.2 Global Venous Leg Ulcers Treatment Sales in Value by Region (2020-2025)
4.2.3 Global Venous Leg Ulcers Treatment Sales (Volume & Value), Price and Gross Margin (2020-2025)
4.3 Global Venous Leg Ulcers Treatment Forecasted Market Size by Region
4.3.1 Global Venous Leg Ulcers Treatment Sales in Volume by Region (2026-2031)
4.3.2 Global Venous Leg Ulcers Treatment Sales in Value by Region (2026-2031)
4.3.3 Global Venous Leg Ulcers Treatment Sales (Volume & Value), Price and Gross Margin (2026-2031)
5 Venous Leg Ulcers Treatment by Application
5.1 Venous Leg Ulcers Treatment Market by Application
5.1.1 Hospital
5.1.2 Clinic
5.1.3 Home Use
5.2 Global Venous Leg Ulcers Treatment Market Size by Application
5.2.1 Global Venous Leg Ulcers Treatment Market Size Overview by Application (2020-2031)
5.2.2 Global Venous Leg Ulcers Treatment Historic Market Size Review by Application (2020-2025)
5.2.3 Global Venous Leg Ulcers Treatment Forecasted Market Size by Application (2026-2031)
5.3 Key Regions Market Size by Application
5.3.1 North America Venous Leg Ulcers Treatment Sales Breakdown by Application (2020-2025)
5.3.2 Europe Venous Leg Ulcers Treatment Sales Breakdown by Application (2020-2025)
5.3.3 Asia-Pacific Venous Leg Ulcers Treatment Sales Breakdown by Application (2020-2025)
5.3.4 South America Venous Leg Ulcers Treatment Sales Breakdown by Application (2020-2025)
5.3.5 Middle East and Africa Venous Leg Ulcers Treatment Sales Breakdown by Application (2020-2025)
6 Company Profiles
6.1 Stratatech Corp
6.1.1 Stratatech Corp Comapny Information
6.1.2 Stratatech Corp Business Overview
6.1.3 Stratatech Corp Venous Leg Ulcers Treatment Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Stratatech Corp Venous Leg Ulcers Treatment Product Portfolio
6.1.5 Stratatech Corp Recent Developments
6.2 RMB-Research GmbH
6.2.1 RMB-Research GmbH Comapny Information
6.2.2 RMB-Research GmbH Business Overview
6.2.3 RMB-Research GmbH Venous Leg Ulcers Treatment Sales, Revenue and Gross Margin (2020-2025)
6.2.4 RMB-Research GmbH Venous Leg Ulcers Treatment Product Portfolio
6.2.5 RMB-Research GmbH Recent Developments
6.3 RegeneRx Biopharmaceuticals Inc
6.3.1 RegeneRx Biopharmaceuticals Inc Comapny Information
6.3.2 RegeneRx Biopharmaceuticals Inc Business Overview
6.3.3 RegeneRx Biopharmaceuticals Inc Venous Leg Ulcers Treatment Sales, Revenue and Gross Margin (2020-2025)
6.3.4 RegeneRx Biopharmaceuticals Inc Venous Leg Ulcers Treatment Product Portfolio
6.3.5 RegeneRx Biopharmaceuticals Inc Recent Developments
6.4 Promore Pharma
6.4.1 Promore Pharma Comapny Information
6.4.2 Promore Pharma Business Overview
6.4.3 Promore Pharma Venous Leg Ulcers Treatment Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Promore Pharma Venous Leg Ulcers Treatment Product Portfolio
6.4.5 Promore Pharma Recent Developments
6.5 NovaLead Pharma Pvt Ltd
6.5.1 NovaLead Pharma Pvt Ltd Comapny Information
6.5.2 NovaLead Pharma Pvt Ltd Business Overview
6.5.3 NovaLead Pharma Pvt Ltd Venous Leg Ulcers Treatment Sales, Revenue and Gross Margin (2020-2025)
6.5.4 NovaLead Pharma Pvt Ltd Venous Leg Ulcers Treatment Product Portfolio
6.5.5 NovaLead Pharma Pvt Ltd Recent Developments
6.6 MediWound Ltd
6.6.1 MediWound Ltd Comapny Information
6.6.2 MediWound Ltd Business Overview
6.6.3 MediWound Ltd Venous Leg Ulcers Treatment Sales, Revenue and Gross Margin (2020-2025)
6.6.4 MediWound Ltd Venous Leg Ulcers Treatment Product Portfolio
6.6.5 MediWound Ltd Recent Developments
6.7 Leap Therapeutics Inc
6.7.1 Leap Therapeutics Inc Comapny Information
6.7.2 Leap Therapeutics Inc Business Overview
6.7.3 Leap Therapeutics Inc Venous Leg Ulcers Treatment Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Leap Therapeutics Inc Venous Leg Ulcers Treatment Product Portfolio
6.7.5 Leap Therapeutics Inc Recent Developments
6.8 Hypo-Stream Ltd
6.8.1 Hypo-Stream Ltd Comapny Information
6.8.2 Hypo-Stream Ltd Business Overview
6.8.3 Hypo-Stream Ltd Venous Leg Ulcers Treatment Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Hypo-Stream Ltd Venous Leg Ulcers Treatment Product Portfolio
6.8.5 Hypo-Stream Ltd Recent Developments
6.9 GangaGen Inc
6.9.1 GangaGen Inc Comapny Information
6.9.2 GangaGen Inc Business Overview
6.9.3 GangaGen Inc Venous Leg Ulcers Treatment Sales, Revenue and Gross Margin (2020-2025)
6.9.4 GangaGen Inc Venous Leg Ulcers Treatment Product Portfolio
6.9.5 GangaGen Inc Recent Developments
6.10 FirstString Research Inc
6.10.1 FirstString Research Inc Comapny Information
6.10.2 FirstString Research Inc Business Overview
6.10.3 FirstString Research Inc Venous Leg Ulcers Treatment Sales, Revenue and Gross Margin (2020-2025)
6.10.4 FirstString Research Inc Venous Leg Ulcers Treatment Product Portfolio
6.10.5 FirstString Research Inc Recent Developments
6.11 Factor Therapeutics Ltd
6.11.1 Factor Therapeutics Ltd Comapny Information
6.11.2 Factor Therapeutics Ltd Business Overview
6.11.3 Factor Therapeutics Ltd Venous Leg Ulcers Treatment Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Factor Therapeutics Ltd Venous Leg Ulcers Treatment Product Portfolio
6.11.5 Factor Therapeutics Ltd Recent Developments
6.12 Daval International Ltd
6.12.1 Daval International Ltd Comapny Information
6.12.2 Daval International Ltd Business Overview
6.12.3 Daval International Ltd Venous Leg Ulcers Treatment Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Daval International Ltd Venous Leg Ulcers Treatment Product Portfolio
6.12.5 Daval International Ltd Recent Developments
6.13 CytoTools AG
6.13.1 CytoTools AG Comapny Information
6.13.2 CytoTools AG Business Overview
6.13.3 CytoTools AG Venous Leg Ulcers Treatment Sales, Revenue and Gross Margin (2020-2025)
6.13.4 CytoTools AG Venous Leg Ulcers Treatment Product Portfolio
6.13.5 CytoTools AG Recent Developments
6.14 CardioVascular BioTherapeutics Inc
6.14.1 CardioVascular BioTherapeutics Inc Comapny Information
6.14.2 CardioVascular BioTherapeutics Inc Business Overview
6.14.3 CardioVascular BioTherapeutics Inc Venous Leg Ulcers Treatment Sales, Revenue and Gross Margin (2020-2025)
6.14.4 CardioVascular BioTherapeutics Inc Venous Leg Ulcers Treatment Product Portfolio
6.14.5 CardioVascular BioTherapeutics Inc Recent Developments
7 North America by Country
7.1 North America Venous Leg Ulcers Treatment Sales by Country
7.1.1 North America Venous Leg Ulcers Treatment Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.1.2 North America Venous Leg Ulcers Treatment Sales by Country (2020-2025)
7.1.3 North America Venous Leg Ulcers Treatment Sales Forecast by Country (2026-2031)
7.2 North America Venous Leg Ulcers Treatment Market Size by Country
7.2.1 North America Venous Leg Ulcers Treatment Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2.2 North America Venous Leg Ulcers Treatment Market Size by Country (2020-2025)
7.2.3 North America Venous Leg Ulcers Treatment Market Size Forecast by Country (2026-2031)
8 Europe by Country
8.1 Europe Venous Leg Ulcers Treatment Sales by Country
8.1.1 Europe Venous Leg Ulcers Treatment Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.1.2 Europe Venous Leg Ulcers Treatment Sales by Country (2020-2025)
8.1.3 Europe Venous Leg Ulcers Treatment Sales Forecast by Country (2026-2031)
8.2 Europe Venous Leg Ulcers Treatment Market Size by Country
8.2.1 Europe Venous Leg Ulcers Treatment Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2.2 Europe Venous Leg Ulcers Treatment Market Size by Country (2020-2025)
8.2.3 Europe Venous Leg Ulcers Treatment Market Size Forecast by Country (2026-2031)
9 Asia-Pacific by Country
9.1 Asia-Pacific Venous Leg Ulcers Treatment Sales by Country
9.1.1 Asia-Pacific Venous Leg Ulcers Treatment Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.1.2 Asia-Pacific Venous Leg Ulcers Treatment Sales by Country (2020-2025)
9.1.3 Asia-Pacific Venous Leg Ulcers Treatment Sales Forecast by Country (2026-2031)
9.2 Asia-Pacific Venous Leg Ulcers Treatment Market Size by Country
9.2.1 Asia-Pacific Venous Leg Ulcers Treatment Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2.2 Asia-Pacific Venous Leg Ulcers Treatment Market Size by Country (2020-2025)
9.2.3 Asia-Pacific Venous Leg Ulcers Treatment Market Size Forecast by Country (2026-2031)
10 South America by Country
10.1 South America Venous Leg Ulcers Treatment Sales by Country
10.1.1 South America Venous Leg Ulcers Treatment Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.1.2 South America Venous Leg Ulcers Treatment Sales by Country (2020-2025)
10.1.3 South America Venous Leg Ulcers Treatment Sales Forecast by Country (2026-2031)
10.2 South America Venous Leg Ulcers Treatment Market Size by Country
10.2.1 South America Venous Leg Ulcers Treatment Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2.2 South America Venous Leg Ulcers Treatment Market Size by Country (2020-2025)
10.2.3 South America Venous Leg Ulcers Treatment Market Size Forecast by Country (2026-2031)
11 Middle East and Africa by Country
11.1 Middle East and Africa Venous Leg Ulcers Treatment Sales by Country
11.1.1 Middle East and Africa Venous Leg Ulcers Treatment Sales Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.1.2 Middle East and Africa Venous Leg Ulcers Treatment Sales by Country (2020-2025)
11.1.3 Middle East and Africa Venous Leg Ulcers Treatment Sales Forecast by Country (2026-2031)
11.2 Middle East and Africa Venous Leg Ulcers Treatment Market Size by Country
11.2.1 Middle East and Africa Venous Leg Ulcers Treatment Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2.2 Middle East and Africa Venous Leg Ulcers Treatment Market Size by Country (2020-2025)
11.2.3 Middle East and Africa Venous Leg Ulcers Treatment Market Size Forecast by Country (2026-2031)
12 Value Chain and Sales Channels Analysis
12.1 Venous Leg Ulcers Treatment Value Chain Analysis
12.1.1 Venous Leg Ulcers Treatment Key Raw Materials
12.1.2 Key Raw Materials Price
12.1.3 Raw Materials Key Suppliers
12.1.4 Manufacturing Cost Structure
12.1.5 Venous Leg Ulcers Treatment Production Mode & Process
12.2 Venous Leg Ulcers Treatment Sales Channels Analysis
12.2.1 Direct Comparison with Distribution Share
12.2.2 Venous Leg Ulcers Treatment Distributors
12.2.3 Venous Leg Ulcers Treatment Customers
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.